Differential Sex Response to Aspirin in Decreasing Aneurysm Rupture in Humans and Mice

We previously found that aspirin decreases the risk of cerebral aneurysm rupture in humans. We aim to assess whether a sex differential exists in the response of human cerebral aneurysms to aspirin and confirm these observations in a mouse model of cerebral aneurysm. A nested case–control analysis f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hypertension (Dallas, Tex. 1979) Tex. 1979), 2016-08, Vol.68 (2), p.411-417
Hauptverfasser: Chalouhi, Nohra, Starke, Robert M, Correa, Tatiana, Jabbour, Pascal M, Zanaty, Mario, Brown, Robert D, Torner, James C, Hasan, David M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 417
container_issue 2
container_start_page 411
container_title Hypertension (Dallas, Tex. 1979)
container_volume 68
creator Chalouhi, Nohra
Starke, Robert M
Correa, Tatiana
Jabbour, Pascal M
Zanaty, Mario
Brown, Robert D
Torner, James C
Hasan, David M
description We previously found that aspirin decreases the risk of cerebral aneurysm rupture in humans. We aim to assess whether a sex differential exists in the response of human cerebral aneurysms to aspirin and confirm these observations in a mouse model of cerebral aneurysm. A nested case–control analysis from the International Study of Unruptured Intracranial Aneurysms was performed to assess whether a sex differential exists in the response of human cerebral aneurysms to aspirin. A series of experiments were subsequently performed in a mouse model of cerebral aneurysms. Aneurysms were induced with hypertension and elastase injection into mice basal cisterns. We found that aspirin decreased the risk of aneurysm rupture more significantly in men than in women in the International Study of Unruptured Intracranial Aneurysms. In mice, aspirin and cyclooxygenase-2 inhibitor did not affect cerebral aneurysm formation but significantly decreased the incidence of rupture. The incidence of rupture was significantly lower in male versus female mice on aspirin. Gene expression analysis from cerebral arteries showed higher 15-hydroxyprostaglandin dehydrogenase levels in male mice. The rate of cerebral aneurysm rupture was similar in male mice receiving aspirin and 15-hydroxyprostaglandin dehydrogenase inhibitor compared with females receiving aspirin and 15-hydroxyprostaglandin dehydrogenase agonist, signaling a reversal of the sex-differential response to aspirin. Aspirin decreases aneurysm rupture in human and mice, in part through cyclooxygenase-2 pathways. Evidence from animal and human studies suggests a consistent differential effect by sex. 15-Hydroxyprostaglandin dehydrogenase activation in females reduces the incidence of rupture and eliminates the sex-differential response to aspirin.
doi_str_mv 10.1161/HYPERTENSIONAHA.116.07515
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4945417</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>27296993</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5035-e65bd903b9f88ffe8c1e3522a938795b42523c9c66c6d8c675c690679d454db73</originalsourceid><addsrcrecordid>eNqNUNtu1DAQtRCILi2_gMwHpPie-AGkqN2ylUpbbVsET5bjTLqGbBLZCaV_j8NCVXhAWGON5nLOzByEXlNySKmib1afL5fr6-X51enFebkq5-QhySWVT9CCSiYyIRV_ihaEapFpSj_toRcxfiGECiHy52iP5UwrrfkCfTz2TQMButHbFl_Bd7yGOPRdBDz2uIyDD77DyY7BBbDRd7e47GAK93GL19MwTgHm8mra2i5i29X4g3dwgJ41to3w8pffRzcny-ujVXZ28f70qDzLnCRcZqBkVWvCK90URdqjcBS4ZMxqXuRaVoJJxp12SjlVF07l0ilNVK5rIUVd5XwfvdvxDlO1hdqlO4JtzRD81oZ701tv_qx0fmNu-29G6MRAZwK9I3ChjzFA84ClxMxim7_EnpPmp9gJ--rx8Afkb3VTw9tdw13fjhDi13a6g2A2YNtx818DxD_wJD3BVJExQhUpUpSlzyT_AeWzobE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Differential Sex Response to Aspirin in Decreasing Aneurysm Rupture in Humans and Mice</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Complete</source><creator>Chalouhi, Nohra ; Starke, Robert M ; Correa, Tatiana ; Jabbour, Pascal M ; Zanaty, Mario ; Brown, Robert D ; Torner, James C ; Hasan, David M</creator><creatorcontrib>Chalouhi, Nohra ; Starke, Robert M ; Correa, Tatiana ; Jabbour, Pascal M ; Zanaty, Mario ; Brown, Robert D ; Torner, James C ; Hasan, David M</creatorcontrib><description>We previously found that aspirin decreases the risk of cerebral aneurysm rupture in humans. We aim to assess whether a sex differential exists in the response of human cerebral aneurysms to aspirin and confirm these observations in a mouse model of cerebral aneurysm. A nested case–control analysis from the International Study of Unruptured Intracranial Aneurysms was performed to assess whether a sex differential exists in the response of human cerebral aneurysms to aspirin. A series of experiments were subsequently performed in a mouse model of cerebral aneurysms. Aneurysms were induced with hypertension and elastase injection into mice basal cisterns. We found that aspirin decreased the risk of aneurysm rupture more significantly in men than in women in the International Study of Unruptured Intracranial Aneurysms. In mice, aspirin and cyclooxygenase-2 inhibitor did not affect cerebral aneurysm formation but significantly decreased the incidence of rupture. The incidence of rupture was significantly lower in male versus female mice on aspirin. Gene expression analysis from cerebral arteries showed higher 15-hydroxyprostaglandin dehydrogenase levels in male mice. The rate of cerebral aneurysm rupture was similar in male mice receiving aspirin and 15-hydroxyprostaglandin dehydrogenase inhibitor compared with females receiving aspirin and 15-hydroxyprostaglandin dehydrogenase agonist, signaling a reversal of the sex-differential response to aspirin. Aspirin decreases aneurysm rupture in human and mice, in part through cyclooxygenase-2 pathways. Evidence from animal and human studies suggests a consistent differential effect by sex. 15-Hydroxyprostaglandin dehydrogenase activation in females reduces the incidence of rupture and eliminates the sex-differential response to aspirin.</description><identifier>ISSN: 0194-911X</identifier><identifier>EISSN: 1524-4563</identifier><identifier>DOI: 10.1161/HYPERTENSIONAHA.116.07515</identifier><identifier>PMID: 27296993</identifier><language>eng</language><publisher>United States: American Heart Association, Inc</publisher><subject><![CDATA[Aneurysm, Ruptured - metabolism ; Aneurysm, Ruptured - pathology ; Aneurysm, Ruptured - prevention & control ; Animals ; Aspirin - administration & dosage ; Aspirin - pharmacokinetics ; Cerebral Arteries - metabolism ; Cerebral Arteries - pathology ; Cyclooxygenase 2 - metabolism ; Cyclooxygenase Inhibitors - administration & dosage ; Cyclooxygenase Inhibitors - pharmacokinetics ; Disease Models, Animal ; Female ; Follow-Up Studies ; Humans ; Hydroxyprostaglandin Dehydrogenases - antagonists & inhibitors ; Hydroxyprostaglandin Dehydrogenases - metabolism ; Incidence ; Intracranial Aneurysm - metabolism ; Intracranial Aneurysm - pathology ; Intracranial Aneurysm - prevention & control ; Male ; Mice ; Risk Factors ; Sex Factors ; Subarachnoid Hemorrhage - etiology ; Subarachnoid Hemorrhage - prevention & control]]></subject><ispartof>Hypertension (Dallas, Tex. 1979), 2016-08, Vol.68 (2), p.411-417</ispartof><rights>2016 American Heart Association, Inc</rights><rights>2016 American Heart Association, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5035-e65bd903b9f88ffe8c1e3522a938795b42523c9c66c6d8c675c690679d454db73</citedby><cites>FETCH-LOGICAL-c5035-e65bd903b9f88ffe8c1e3522a938795b42523c9c66c6d8c675c690679d454db73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,3674,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27296993$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chalouhi, Nohra</creatorcontrib><creatorcontrib>Starke, Robert M</creatorcontrib><creatorcontrib>Correa, Tatiana</creatorcontrib><creatorcontrib>Jabbour, Pascal M</creatorcontrib><creatorcontrib>Zanaty, Mario</creatorcontrib><creatorcontrib>Brown, Robert D</creatorcontrib><creatorcontrib>Torner, James C</creatorcontrib><creatorcontrib>Hasan, David M</creatorcontrib><title>Differential Sex Response to Aspirin in Decreasing Aneurysm Rupture in Humans and Mice</title><title>Hypertension (Dallas, Tex. 1979)</title><addtitle>Hypertension</addtitle><description>We previously found that aspirin decreases the risk of cerebral aneurysm rupture in humans. We aim to assess whether a sex differential exists in the response of human cerebral aneurysms to aspirin and confirm these observations in a mouse model of cerebral aneurysm. A nested case–control analysis from the International Study of Unruptured Intracranial Aneurysms was performed to assess whether a sex differential exists in the response of human cerebral aneurysms to aspirin. A series of experiments were subsequently performed in a mouse model of cerebral aneurysms. Aneurysms were induced with hypertension and elastase injection into mice basal cisterns. We found that aspirin decreased the risk of aneurysm rupture more significantly in men than in women in the International Study of Unruptured Intracranial Aneurysms. In mice, aspirin and cyclooxygenase-2 inhibitor did not affect cerebral aneurysm formation but significantly decreased the incidence of rupture. The incidence of rupture was significantly lower in male versus female mice on aspirin. Gene expression analysis from cerebral arteries showed higher 15-hydroxyprostaglandin dehydrogenase levels in male mice. The rate of cerebral aneurysm rupture was similar in male mice receiving aspirin and 15-hydroxyprostaglandin dehydrogenase inhibitor compared with females receiving aspirin and 15-hydroxyprostaglandin dehydrogenase agonist, signaling a reversal of the sex-differential response to aspirin. Aspirin decreases aneurysm rupture in human and mice, in part through cyclooxygenase-2 pathways. Evidence from animal and human studies suggests a consistent differential effect by sex. 15-Hydroxyprostaglandin dehydrogenase activation in females reduces the incidence of rupture and eliminates the sex-differential response to aspirin.</description><subject>Aneurysm, Ruptured - metabolism</subject><subject>Aneurysm, Ruptured - pathology</subject><subject>Aneurysm, Ruptured - prevention &amp; control</subject><subject>Animals</subject><subject>Aspirin - administration &amp; dosage</subject><subject>Aspirin - pharmacokinetics</subject><subject>Cerebral Arteries - metabolism</subject><subject>Cerebral Arteries - pathology</subject><subject>Cyclooxygenase 2 - metabolism</subject><subject>Cyclooxygenase Inhibitors - administration &amp; dosage</subject><subject>Cyclooxygenase Inhibitors - pharmacokinetics</subject><subject>Disease Models, Animal</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Hydroxyprostaglandin Dehydrogenases - antagonists &amp; inhibitors</subject><subject>Hydroxyprostaglandin Dehydrogenases - metabolism</subject><subject>Incidence</subject><subject>Intracranial Aneurysm - metabolism</subject><subject>Intracranial Aneurysm - pathology</subject><subject>Intracranial Aneurysm - prevention &amp; control</subject><subject>Male</subject><subject>Mice</subject><subject>Risk Factors</subject><subject>Sex Factors</subject><subject>Subarachnoid Hemorrhage - etiology</subject><subject>Subarachnoid Hemorrhage - prevention &amp; control</subject><issn>0194-911X</issn><issn>1524-4563</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNUNtu1DAQtRCILi2_gMwHpPie-AGkqN2ylUpbbVsET5bjTLqGbBLZCaV_j8NCVXhAWGON5nLOzByEXlNySKmib1afL5fr6-X51enFebkq5-QhySWVT9CCSiYyIRV_ihaEapFpSj_toRcxfiGECiHy52iP5UwrrfkCfTz2TQMButHbFl_Bd7yGOPRdBDz2uIyDD77DyY7BBbDRd7e47GAK93GL19MwTgHm8mra2i5i29X4g3dwgJ41to3w8pffRzcny-ujVXZ28f70qDzLnCRcZqBkVWvCK90URdqjcBS4ZMxqXuRaVoJJxp12SjlVF07l0ilNVK5rIUVd5XwfvdvxDlO1hdqlO4JtzRD81oZ701tv_qx0fmNu-29G6MRAZwK9I3ChjzFA84ClxMxim7_EnpPmp9gJ--rx8Afkb3VTw9tdw13fjhDi13a6g2A2YNtx818DxD_wJD3BVJExQhUpUpSlzyT_AeWzobE</recordid><startdate>201608</startdate><enddate>201608</enddate><creator>Chalouhi, Nohra</creator><creator>Starke, Robert M</creator><creator>Correa, Tatiana</creator><creator>Jabbour, Pascal M</creator><creator>Zanaty, Mario</creator><creator>Brown, Robert D</creator><creator>Torner, James C</creator><creator>Hasan, David M</creator><general>American Heart Association, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>201608</creationdate><title>Differential Sex Response to Aspirin in Decreasing Aneurysm Rupture in Humans and Mice</title><author>Chalouhi, Nohra ; Starke, Robert M ; Correa, Tatiana ; Jabbour, Pascal M ; Zanaty, Mario ; Brown, Robert D ; Torner, James C ; Hasan, David M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5035-e65bd903b9f88ffe8c1e3522a938795b42523c9c66c6d8c675c690679d454db73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Aneurysm, Ruptured - metabolism</topic><topic>Aneurysm, Ruptured - pathology</topic><topic>Aneurysm, Ruptured - prevention &amp; control</topic><topic>Animals</topic><topic>Aspirin - administration &amp; dosage</topic><topic>Aspirin - pharmacokinetics</topic><topic>Cerebral Arteries - metabolism</topic><topic>Cerebral Arteries - pathology</topic><topic>Cyclooxygenase 2 - metabolism</topic><topic>Cyclooxygenase Inhibitors - administration &amp; dosage</topic><topic>Cyclooxygenase Inhibitors - pharmacokinetics</topic><topic>Disease Models, Animal</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Hydroxyprostaglandin Dehydrogenases - antagonists &amp; inhibitors</topic><topic>Hydroxyprostaglandin Dehydrogenases - metabolism</topic><topic>Incidence</topic><topic>Intracranial Aneurysm - metabolism</topic><topic>Intracranial Aneurysm - pathology</topic><topic>Intracranial Aneurysm - prevention &amp; control</topic><topic>Male</topic><topic>Mice</topic><topic>Risk Factors</topic><topic>Sex Factors</topic><topic>Subarachnoid Hemorrhage - etiology</topic><topic>Subarachnoid Hemorrhage - prevention &amp; control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chalouhi, Nohra</creatorcontrib><creatorcontrib>Starke, Robert M</creatorcontrib><creatorcontrib>Correa, Tatiana</creatorcontrib><creatorcontrib>Jabbour, Pascal M</creatorcontrib><creatorcontrib>Zanaty, Mario</creatorcontrib><creatorcontrib>Brown, Robert D</creatorcontrib><creatorcontrib>Torner, James C</creatorcontrib><creatorcontrib>Hasan, David M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chalouhi, Nohra</au><au>Starke, Robert M</au><au>Correa, Tatiana</au><au>Jabbour, Pascal M</au><au>Zanaty, Mario</au><au>Brown, Robert D</au><au>Torner, James C</au><au>Hasan, David M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differential Sex Response to Aspirin in Decreasing Aneurysm Rupture in Humans and Mice</atitle><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle><addtitle>Hypertension</addtitle><date>2016-08</date><risdate>2016</risdate><volume>68</volume><issue>2</issue><spage>411</spage><epage>417</epage><pages>411-417</pages><issn>0194-911X</issn><eissn>1524-4563</eissn><abstract>We previously found that aspirin decreases the risk of cerebral aneurysm rupture in humans. We aim to assess whether a sex differential exists in the response of human cerebral aneurysms to aspirin and confirm these observations in a mouse model of cerebral aneurysm. A nested case–control analysis from the International Study of Unruptured Intracranial Aneurysms was performed to assess whether a sex differential exists in the response of human cerebral aneurysms to aspirin. A series of experiments were subsequently performed in a mouse model of cerebral aneurysms. Aneurysms were induced with hypertension and elastase injection into mice basal cisterns. We found that aspirin decreased the risk of aneurysm rupture more significantly in men than in women in the International Study of Unruptured Intracranial Aneurysms. In mice, aspirin and cyclooxygenase-2 inhibitor did not affect cerebral aneurysm formation but significantly decreased the incidence of rupture. The incidence of rupture was significantly lower in male versus female mice on aspirin. Gene expression analysis from cerebral arteries showed higher 15-hydroxyprostaglandin dehydrogenase levels in male mice. The rate of cerebral aneurysm rupture was similar in male mice receiving aspirin and 15-hydroxyprostaglandin dehydrogenase inhibitor compared with females receiving aspirin and 15-hydroxyprostaglandin dehydrogenase agonist, signaling a reversal of the sex-differential response to aspirin. Aspirin decreases aneurysm rupture in human and mice, in part through cyclooxygenase-2 pathways. Evidence from animal and human studies suggests a consistent differential effect by sex. 15-Hydroxyprostaglandin dehydrogenase activation in females reduces the incidence of rupture and eliminates the sex-differential response to aspirin.</abstract><cop>United States</cop><pub>American Heart Association, Inc</pub><pmid>27296993</pmid><doi>10.1161/HYPERTENSIONAHA.116.07515</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0194-911X
ispartof Hypertension (Dallas, Tex. 1979), 2016-08, Vol.68 (2), p.411-417
issn 0194-911X
1524-4563
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4945417
source MEDLINE; American Heart Association Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Complete
subjects Aneurysm, Ruptured - metabolism
Aneurysm, Ruptured - pathology
Aneurysm, Ruptured - prevention & control
Animals
Aspirin - administration & dosage
Aspirin - pharmacokinetics
Cerebral Arteries - metabolism
Cerebral Arteries - pathology
Cyclooxygenase 2 - metabolism
Cyclooxygenase Inhibitors - administration & dosage
Cyclooxygenase Inhibitors - pharmacokinetics
Disease Models, Animal
Female
Follow-Up Studies
Humans
Hydroxyprostaglandin Dehydrogenases - antagonists & inhibitors
Hydroxyprostaglandin Dehydrogenases - metabolism
Incidence
Intracranial Aneurysm - metabolism
Intracranial Aneurysm - pathology
Intracranial Aneurysm - prevention & control
Male
Mice
Risk Factors
Sex Factors
Subarachnoid Hemorrhage - etiology
Subarachnoid Hemorrhage - prevention & control
title Differential Sex Response to Aspirin in Decreasing Aneurysm Rupture in Humans and Mice
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T00%3A08%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differential%20Sex%20Response%20to%20Aspirin%20in%20Decreasing%20Aneurysm%20Rupture%20in%20Humans%20and%20Mice&rft.jtitle=Hypertension%20(Dallas,%20Tex.%201979)&rft.au=Chalouhi,%20Nohra&rft.date=2016-08&rft.volume=68&rft.issue=2&rft.spage=411&rft.epage=417&rft.pages=411-417&rft.issn=0194-911X&rft.eissn=1524-4563&rft_id=info:doi/10.1161/HYPERTENSIONAHA.116.07515&rft_dat=%3Cpubmed_cross%3E27296993%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/27296993&rfr_iscdi=true